July 17th 2024
A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
EFSA Schedules Consultation on Gut Health and Immune Function Health Claims
August 12th 2010As part of the European Food Safety Authority's (EFSA; Parma, Italy) ongoing series of public consultations on health claims guidance, the agency has announced that it will hold a meeting on scientific requirements for gut health and immune function health claims on December 2, 2010, in Amsterdam.
New CoQ10 Powder Offers Improved Liquid Blending
May 26th 2010Ingredient supplier Triarco (Wayne, NJ) has launched Aqua 10, a patented water-soluble coenzyme Q10 (CoQ10) powder designed for optimal dry and liquid blending. CoQ10 can be difficult to incorporate in beverages and other products because of its molecular weight and characteristic solubility-factors that can also hinder bioavailability, says the company. It says that Aqua 10 demonstrates approximately 50% better absorption when compared with typical CoQ10.
Swedish Researchers Link Fish Consumption to Improved Intelligence
July 6th 2009Researchers in Sweden may have discovered a connection between fish consumption and higher intelligence scores among teenage males, according to omega-3 ingredient supplier Ocean Nutrition Canada (ONC; Dartmouth, NS).
Alzheimers Not Significantly Helped By Vitamin B Supplementation
October 9th 2008A new study in the October 15 issue of the Journal of the American Medical Association (JAMA; Chicago) shows that high-doses of vitamin B supplementation do little to reduce the speed of cognitive decline in Alzheimer patients.
German Study Supports St. John's Wort Depression Claim
October 9th 2008The plant extract of Hypericum perforatum, or St. John’s wort, is grown on nearly every continent in the world, but has only recently been scientifically cited as a potential gatekeeper for depression. The study, reported in the Cochrane Systematic Review (United Kingdom) in October, included reviews of 29 trials with a total of 5,489 patients prescribed with symptoms of “major depression.”
NIH-Supported Researchers Launch Nationwide Omega-3 Trial
May 19th 2008Researchers supported by the National Institute on Aging (NIA), part of the National Institutes of Health (Bethesda, MD), will conduct a nationwide clinical trial to invesigate whether omega-3 fatty acids slow Alzeimer's disease.
Practitioner's Guide to Nutritional Supplements
June 15th 2007Lack of communication between doctors and patients poses a serious problem for the healthcare industry, especially when it comes to complementary and alternative medicine (CAM). According to the National Center for Complementary and Alternative Medicine (NCCAM; Bethesda, MD), only about 12% of Americans who tried CAM between 1997 and 2004 consulted a licensed healthcare practitioner.
Research Mounts on Benefits of Omega-3s
January 19th 2007Two recent studies from the Archives of Neurology suggest that omega-3 fatty acids may be helpful for people suffering from cognitive decline. The studies, while not definitive, add more support to the theory that the omega-3s docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are important elements of cognitive health and well-being.